This indefinite delivery contract was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Xlcare Pharmaceuticals, Inc. to supply gabapentin capsules in various package sizes to meet the estimated annual needs of the VA, Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS).
The single-award, indefinite delivery contract has a total ceiling value of $54,110,891.35 and a base period of performance from November 11, 2023 through November 10, 2024 with four one-year option periods. Xlcare Pharmaceuticals, a minority-owned, small disadvantaged business, will provide over 3 million gabapentin capsules across 13 product presentations ranging from 30-count to 1,000-count bottles. The contract will utilize the VA and DoD's respective pharmaceutical prime vendor programs for distribution to the various government healthcare facilities. This unrestricted procurement was solicited under NAICS code 325412 and did not have a set-aside designation.
Generated 9/26/24, 9:08 AM